Zions Bancorporation’s Ionis Pharmaceuticals IONS Stock Holding History

Zions Bancorporation’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-83	Closed	-$3K	–	1029
2021 Q3	$3K	Sell	83 -183	-69%	-$6.89K	﹤0.01%	886
2021 Q2	$11K	Buy	266 +203	+322%	+$7.95K	﹤0.01%	711
2021 Q1	$3K	Hold	63	–	–	﹤0.01%	853
2020 Q4	$4K	Sell	63 -27	-30%	-$1.34K	﹤0.01%	811
2020 Q3	$4K	Buy	90 +44	+96%	+$2.44K	﹤0.01%	845
2020 Q2	$3K	Buy	+46	New	+$2.56K	﹤0.01%	800
2017 Q3	–	Sell	-300	Closed	-$15K	–	1065
2017 Q2	$15K	Buy	+300	New	+$14K	﹤0.01%	305
2015 Q2	–	Sell	-17	Closed	-$1K	–	489
2015 Q1	$1K	Buy	+17	New	+$1.15K	﹤0.01%	869

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Zions Bancorporation's IONS Position: Q4 2021 in Review

Zions Bancorporation sold out of Ionis Pharmaceuticals (IONS) in Q4 2021, closing a stake of 83 shares — an estimated $3K sold.

Zions Bancorporation first reported a position in IONS in Q1 2015 and held it in 8 quarters. The position peaked at $15K in Q2 2017. 340 funds tracked by Wall St. Rank hold IONS as of Q4 2021.

Zions Bancorporation reported no remaining Ionis Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Zions Bancorporation sold 83 Ionis Pharmaceuticals shares in Q4 2021, an estimated $3K.
Zions Bancorporation first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 8 quarters.
Zions Bancorporation's Ionis Pharmaceuticals position peaked at $15K in Q2 2017.
340 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2021.

Based on Zions Bancorporation's 13F filing for Q4 2021, filed 11 Feb 2022.